LIJENTA-M 2.5 mg + 500 mg contains
Linagliptin 2.5 mg + Metformin Hydrochloride 500 mg. It is a combination oral antidiabetic medicine used to control blood glucose levels in adults with
type 2 diabetes mellitus. Linagliptin helps increase insulin release and improve glucose regulation, while metformin reduces glucose production in the liver and improves insulin sensitivity.